Molecular Pathways: Targeting the Protein Kinase Wee1 in Cancer von Geenen, Jill J J, Schellens, Jan H M

Volltext

PARP Inhibitors in the Treatment of Triple-Negative Breast Cancer von Geenen, Jill J. J., Linn, Sabine C., Beijnen, Jos H., Schellens, Jan H. M.

Volltext

Adavosertib with Chemotherapy in Patients with Primary Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer: An Open-Label, Four-Arm, Phase II Study von Moore, Kathleen N, Chambers, Setsuko K, Hamilton, Erika P, Chen, Lee-May, Oza, Amit M, Ghamande, Sharad A, Konecny, Gottfried E, Plaxe, Steven C, Spitz, Daniel L, Geenen, Jill J J, Troso-Sandoval, Tiffany A, Cragun, Janiel M, Rodrigo Imedio, Esteban, Kumar, Sanjeev, Mugundu, Ganesh M, Lai, Zhongwu, Chmielecki, Juliann, Jones, Suzanne F, Spigel, David R, Cadoo, Karen A

Volltext

WEE1 inhibitor adavosertib in combination with carboplatin in advanced TP53 mutated ovarian cancer: A biomarker-enriched phase II study von Embaby, Alaa, Kutzera, Joachim, Geenen, Jill J., Pluim, Dick, Hofland, Ingrid, Sanders, Joyce, Lopez-Yurda, Marta, Beijnen, Jos H., Huitema, Alwin D.R., Witteveen, Petronella O., Steeghs, Neeltje, van Haaften, Gijs, van Vugt, Marcel A.T.M., de Ridder, Jeroen, Opdam, Frans L.

Volltext

A Phase I dose‐escalation study of two cycles carboplatin‐olaparib followed by olaparib monotherapy in patients with advanced cancer von Geenen, Jill J. J., Dackus, Gwen M. H. E., Schouten, Philip C., Pluim, Dick, Marchetti, Serena, Sonke, Gabe S., Jóźwiak, Katarzyna, Huitema, Alwin D. R., Beijnen, Jos H., Schellens, Jan H. M., Linn, Sabine C.

Volltext

Molecular Pathways: Targeting the Protein Kinase Wee1 in Cancer von Geenen, Jill J, Schellens, Jan H M

Volltext

A Phase I dose-escalation study of two cycles carboplatin-olaparib followed by olaparib monotherapy in patients with advanced cancer von Geenen, Jill J J, Dackus, Gwen M H E, Schouten, Philip C, Pluim, Dick, Marchetti, Serena, Sonke, Gabe S, Jóźwiak, Katarzyna, Huitema, Alwin D R, Beijnen, Jos H, Schellens, Jan H M, Linn, Sabine C

Volltext

PARP Inhibitors in the Treatment of Triple-Negative Breast Cancer von Geenen, Jill J, Linn, Sabine C, Beijnen, Jos H, Schellens, Jan H M

Volltext